Cargando…
Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
The proteomic profile of extracellular vesicles (EVs) from cerebrospinal fluid (CSF) can reveal novel biomarkers for diseases of the brain. Here, we validate an ultrafiltration combined with size-exclusion chromatography (UF-SEC) method for isolation of EVs from canine CSF and probe the effect of st...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261101/ https://www.ncbi.nlm.nih.gov/pubmed/37308520 http://dx.doi.org/10.1038/s41598-023-36706-z |
_version_ | 1785057881123454976 |
---|---|
author | Kangas, Petra Nyman, Tuula A. Metsähonkala, Liisa Burns, Cameron Tempest, Robert Williams, Tim Karttunen, Jenni Jokinen, Tarja S. |
author_facet | Kangas, Petra Nyman, Tuula A. Metsähonkala, Liisa Burns, Cameron Tempest, Robert Williams, Tim Karttunen, Jenni Jokinen, Tarja S. |
author_sort | Kangas, Petra |
collection | PubMed |
description | The proteomic profile of extracellular vesicles (EVs) from cerebrospinal fluid (CSF) can reveal novel biomarkers for diseases of the brain. Here, we validate an ultrafiltration combined with size-exclusion chromatography (UF-SEC) method for isolation of EVs from canine CSF and probe the effect of starting volume on the EV proteomics profile. First, we performed a literature review of CSF EV articles to define the current state of art, discovering a need for basic characterisation of CSF EVs. Secondly, we isolated EVs from CSF by UF-SEC and characterised the SEC fractions by protein amount, particle count, transmission electron microscopy, and immunoblotting. Data are presented as mean ± standard deviation. Using proteomics, SEC fractions 3–5 were compared and enrichment of EV markers in fraction 3 was detected, whereas fractions 4–5 contained more apolipoproteins. Lastly, we compared starting volumes of pooled CSF (6 ml, 3 ml, 1 ml, and 0.5 ml) to evaluate the effect on the proteomic profile. Even with a 0.5 ml starting volume, 743 ± 77 or 345 ± 88 proteins were identified depending on whether ‘matches between runs’ was active in MaxQuant. The results confirm that UF-SEC effectively isolates CSF EVs and that EV proteomic analysis can be performed from 0.5 ml of canine CSF. |
format | Online Article Text |
id | pubmed-10261101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-102611012023-06-15 Towards optimised extracellular vesicle proteomics from cerebrospinal fluid Kangas, Petra Nyman, Tuula A. Metsähonkala, Liisa Burns, Cameron Tempest, Robert Williams, Tim Karttunen, Jenni Jokinen, Tarja S. Sci Rep Article The proteomic profile of extracellular vesicles (EVs) from cerebrospinal fluid (CSF) can reveal novel biomarkers for diseases of the brain. Here, we validate an ultrafiltration combined with size-exclusion chromatography (UF-SEC) method for isolation of EVs from canine CSF and probe the effect of starting volume on the EV proteomics profile. First, we performed a literature review of CSF EV articles to define the current state of art, discovering a need for basic characterisation of CSF EVs. Secondly, we isolated EVs from CSF by UF-SEC and characterised the SEC fractions by protein amount, particle count, transmission electron microscopy, and immunoblotting. Data are presented as mean ± standard deviation. Using proteomics, SEC fractions 3–5 were compared and enrichment of EV markers in fraction 3 was detected, whereas fractions 4–5 contained more apolipoproteins. Lastly, we compared starting volumes of pooled CSF (6 ml, 3 ml, 1 ml, and 0.5 ml) to evaluate the effect on the proteomic profile. Even with a 0.5 ml starting volume, 743 ± 77 or 345 ± 88 proteins were identified depending on whether ‘matches between runs’ was active in MaxQuant. The results confirm that UF-SEC effectively isolates CSF EVs and that EV proteomic analysis can be performed from 0.5 ml of canine CSF. Nature Publishing Group UK 2023-06-12 /pmc/articles/PMC10261101/ /pubmed/37308520 http://dx.doi.org/10.1038/s41598-023-36706-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Kangas, Petra Nyman, Tuula A. Metsähonkala, Liisa Burns, Cameron Tempest, Robert Williams, Tim Karttunen, Jenni Jokinen, Tarja S. Towards optimised extracellular vesicle proteomics from cerebrospinal fluid |
title | Towards optimised extracellular vesicle proteomics from cerebrospinal fluid |
title_full | Towards optimised extracellular vesicle proteomics from cerebrospinal fluid |
title_fullStr | Towards optimised extracellular vesicle proteomics from cerebrospinal fluid |
title_full_unstemmed | Towards optimised extracellular vesicle proteomics from cerebrospinal fluid |
title_short | Towards optimised extracellular vesicle proteomics from cerebrospinal fluid |
title_sort | towards optimised extracellular vesicle proteomics from cerebrospinal fluid |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261101/ https://www.ncbi.nlm.nih.gov/pubmed/37308520 http://dx.doi.org/10.1038/s41598-023-36706-z |
work_keys_str_mv | AT kangaspetra towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid AT nymantuulaa towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid AT metsahonkalaliisa towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid AT burnscameron towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid AT tempestrobert towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid AT williamstim towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid AT karttunenjenni towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid AT jokinentarjas towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid |